Statins may prevent cardiac dysfunction in patients taking anthracyclines

NEW ORLEANS — In the STOP-CA trial, prophylactic atorvastatin therapy reduced the occurrence of anthracycline-associated left ventricular dysfunction at 12 months among patients who underwent treatment for Hodgkin and non-Hodgkin lymphoma.“Anthracyclines are a standard chemotherapy drug used in the treatment of breast cancer and lymphoma. Anthracyclines are prescribed to more than 1

Related Keywords

Massachusetts ,United States ,Byscott Buzby ,Katie Kalvaitis ,Tomasg Neilan ,Amgen ,American College Of Cardiology Scientific Session ,Sanofi Aventis ,Astrazeneca ,Genentech ,Bristol Myers Squibb ,American College ,Cardiology Late Breaking Clinical ,Cardiology Scientific Session ,New Orleans ,Intrinsic Imaging ,Bristol Myers ,Massachusetts General Hospital ,Cardiology Scientific ,